Furthermore, inhibition of growth factors like forkhead box M1 (FOXM1) and polo-like kinase 1 (PLK1) in PAH-PASMCs displayed a significant reduction of cell cycle component AurB [63], suggesting that targeting AurB kinase might have beneficial effects in treating PH. Here, PLK1 is linked to pulmonary arterial hypertension.